Chronic Myeloid Leukemia

1. Cytogenetics of Chronic Myeloid Leukemia (CML)
Bettina Balk, Alice Fabarius, Claudia Haferlach

2. The Biology and Pathogenesis of Chronic Myeloid Leukemia
Bradley Chereda, Junia V. Melo

3. The Choice of First-Line Chronic Myelogenous Leukemia Treatment
Carmen Fava, Giovanna Rege-Cambrin, Irene Dogliotti, Giuseppe Saglio

4. A Review and an Update of European LeukemiaNet Recommendations for the Management of Chronic Myeloid Leukemia
Michele Baccarani, Gabriele Gugliotta, Fausto Castagnetti, Simona Soverini, Gianantonio Rosti

5. Management of Adverse Events Associated with ATP-Competitive BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Delphine Rea

6. Standardization of Molecular Monitoring for Chronic Myeloid Leukemia
Nicholas C. P. Cross, Andreas Hochhaus

7. Epidemiology of Chronic Myeloid Leukemia
Martin Höglund, Fredrik Sandin, Bengt Simonsson

8. Prognostic Scores for Patients with Chronic Myeloid Leukemia Under Particular Consideration of Disease-Specific Death
Markus Pfirrmann, Michael Lauseker, Verena S. Hoffmann, Joerg Hasford

9. Response-Related Predictors of Survival in CML
Benjamin Hanfstein, Martin C. Müller, Andreas Hochhaus

10. CML Blast Crisis: Implications and Management
Rüdiger Hehlmann, Susanne Saußele, Richard T. Silver

11. Managing Pregnancy in Chronic Myeloid Leukemia
Renuka Palani, Dragana Milojkovic, Jane F. Apperley

12. The Role of Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia
Alois Gratwohl

13. Discontinuation or Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia Patients with Deep Molecular Response
Francois-Xavier Mahon, Susanne Saußele

14. The Interferon Alpha Revival in CML
Moshe Talpaz, Jessica Mercer, Rüdiger Hehlmann

15. Changing the Cost of Care for Chronic Myeloid Leukemia: The Availability of Generic Imatinib in the USA and the EU
Rena M. Conti, William V. Padula, Richard A. Larson

Keywords: Medicine & Public Health, Hematology